Ms Brown's daughter, Megan Johnson, 29, said a drug treatment called Phesgo had changed her mum's life and allowed her to ...

Corcept Therapeutics said on Monday its experimental drug in combination with chemotherapy helped delay progression of a type ...

The European Commission on Friday approved AstraZeneca Plc (NASDAQ:AZN) and Daiichi Sankyo's (OTC:DSKNY) Enhertu (trastuzumab ...

Some commonly prescribed photosensitizing drugs increase skin cancer risk, according to a study published online March 18 in ...

Seth Wander, MD, PhD, discusses the tolerability of selective estrogen receptor degraders and next-generation anti-estrogen ...

HealthDay News — Some commonly prescribed photosensitizing drugs increase skin cancer risk, according to a study published online March 18 in Photodermatology, Photoimmunology & Photomedicine.

The U.S Food & Drug Administration has granted approval for a targeted therapy called CABOMETYX ® to treat pancreatic ...

C, provided insights on what to consider when treating patients with HR+, HER2- breast cancer in the second line of treatment.

and colleagues assessed whether the use of commonly prescribed photosensitizing drugs increases skin cancer risk. The researchers found that hormone replacement therapy significantly increased the ...

Most women with breast cancer who paused endocrine therapy to get pregnant did not restart treatment after having a child, ...

Novartis’ radioligand therapy Pluvicto (lutetium Lu 177 vipivotide tetraxetan) has been approved by the US Food and Drug ...

The trial outcomes are said to support a new drug application in the US and a European marketing authorisation application.